Cancer Clinical Trial -Sidney Kimmel Comprehensive Cancer Center-J2177
Cancer
Status:
OpenClinicalTrials.gov:
NCT05013216Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer